Markets

Invigorated Business Consulting Limited Announces Trading Window Closure
Invigorated Business Consulting Limited Announces Trading Window Closure Invigorated Business Consulting Limited announced the closure of its trading window for equity shares, effective April 1, 2026. The closure is in accordance with the company’s code of conduct designed to regulate insider trading, as stipulated by the Securities and Exchange Board of India (SEBI) Regulations of 2015.The trading window will remain closed until 48 hours after the announcement of the company's audited financial results for the quarter and fiscal year concluding March 31, 2026.The date for the board meeting where the financial results will be declared will be communicated at a later time. Invigorated Business Consulting Limited is headquartered at...
UVS Hospitality and Services Limited Holds Extraordinary General Meeting
UVS Hospitality and Services Limited Holds Extraordinary General Meeting UVS Hospitality and Services Limited (formerly Thirdwave Financial Intermediaries Ltd) held an Extraordinary General Meeting (EGM) on March 20, 2026, at 1:00 p.m. via Video Conferencing (VC)/Other Audio-Visual Means (OAVM). Chairman Utkarsh Vartak welcomed attendees and informed them that the meeting was conducted in accordance with the Companies Act, 2013 and applicable regulations.Shareholders were provided the opportunity to vote through remote e-voting from March 17 to March 19, 2026, and continued e-voting was available during the EGM. Hemang Satra & Associates was appointed as the Scrutiniser for the e-voting process. Results will be declared following the...
Inter Globe Finance Ltd. Closes Trading Window Ahead of FY26 Audited Results
Inter Globe Finance Ltd. Closes Trading Window Ahead of FY26 Audited Results Inter Globe Finance Ltd. announced that it will close its trading window for designated persons, starting April 1, 2026. This closure will remain in effect until 48 hours after the declaration of the company’s audited financial results for the quarter and year ended March 31, 2026.The date for the board meeting to review the audited financial results for the quarter and year ended March 31, 2026, will be announced separately. The move adheres to the provisions of Schedule B of the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, and the company’s Code of Conduct and Code of Fair Disclosure.Source:
Triochem Products Ltd. Holds Independent Director’s Meeting
Triochem Products Ltd. Holds Independent Director’s Meeting Triochem Products Ltd. convened a meeting of its Independent Directors on Friday, March 20, 2026, at its registered office in Mumbai. The meeting began at 3:00 p.m. and concluded at 4:10 p.m.The agenda for the meeting included a review of the performance of Non-Independent Directors and the Board overall. Additionally, the Board assessed the performance of the company’s chairperson. Discussions also centered on evaluating the quality, quantity, and timeliness of information flow between company management and the Board, ensuring the Board's ability to fulfill its duties effectively. Source:
YES BANK Allots Equity Shares Through Employee Stock Option Exercises
YES BANK Allots Equity Shares Through Employee Stock Option Exercises YES BANK Limited announced the allotment of 1,26,250 equity shares on March 20, 2026, following the exercise of stock options under the YBL PESOP 2020 Plan within the YBL ESOS 2020 Scheme and the YBL RSU Plan 2024. The exercise of these options generated Rs. 10,17,437.50 for the bank.The allotment has increased the bank's paid-up share capital from Rs. 62,759,261,614, comprised of 31,379,630,807 equity shares, to Rs. 62,759,514,114, now consisting of 31,379,757,057 equity shares.Additional details regarding this allotment are available on the bank's website, www.yes.bank.in. Source:
Athena Global Technologies Limited Issues Corrigendum to Extraordinary General Meeting Notice
Athena Global Technologies Limited Issues Corrigendum to Extraordinary General Meeting Notice Athena Global Technologies Limited announced a corrigendum to the notice of its Extraordinary General Meeting (EGM) scheduled for Wednesday, March 25, 2026, at 12:00 P.M. (IST) via video conferencing. The original EGM notice was electronically distributed to shareholders on March 02, 2026.The corrigendum, released on March 20, 2026, amends the explanatory statement to include disclosure of pre-issue and post-issue share capital, along with the percentage of post-issue shareholding of the proposed allottee, in accordance with the requirements of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements)...
Prabhav Industries Ltd. Independent Directors Review Board Performance
Prabhav Industries Ltd. Independent Directors Review Board Performance Prabhav Industries Ltd. announced on March 20, 2026, that a meeting of its Independent Directors was held on Friday, March 20, 2026, at the company’s registered office.During the meeting, the Independent Directors reviewed the performance of non-independent directors and the board of directors as a whole. They also reviewed the performance of the chairperson, considering the perspectives of executive and non-executive directors. Furthermore, the assessment included the quality, quantity, and timeliness of information flow between the company’s management and the board of directors, to ensure the board can effectively fulfill its duties.The meeting commenced at...
Indogulf Cropsciences Ltd. Announces Resignation of Secretarial Auditor
Indogulf Cropsciences Ltd. Announces Resignation of Secretarial Auditor Indogulf Cropsciences Limited announced on March 20, 2026, that Mr. Deepak Rawat has resigned from his position as Secretarial Auditor, effective March 17, 2026. The resignation is attributed to health issues and other medical reasons.Mr. Rawat, Practicing Company Secretary (ACS: 33210/CP: 12241), confirmed that there are no other material reasons for his departure.Below is a summary of the details pertaining to the resignation:ParticularsDetailsName of Secretarial AuditorMr. Deepak Rawat, Practicing Company Secretary (ACS: 33210/CP: 12241)Reason for ResignationHealth issues and other medical reasonsDate of ResignationMarch 17, 2026Mr. Rawat...
SM Auto Stamping Limited Receives Show Cause Notice from DGFT
SM Auto Stamping Limited Receives Show Cause Notice from DGFT SM Auto Stamping Limited announced today, March 20, 2026, that it has received a Show Cause Notice from the Assistant Director General of Foreign Trade (DGFT), Regional Authority Pune.The notice, received on March 20, 2026, and dated March 18, 2026, concerns a potential violation of the Foreign Trade (Development and Regulation) Act, 1992. The department has issued the notice under section 14 for action under sections 9, 11, and 13 of the Act.According to the notice, SM Auto Stamping Limited is required to demonstrate compliance with conditions stipulated in its license. A hearing regarding the matter is scheduled for April 9, 2026.The company stated that the notice is...
Eris Lifesciences Launches Generic Semaglutide ‘SUNDAE’ in India
Eris Lifesciences Launches Generic Semaglutide ‘SUNDAE’ in India Eris Lifesciences Limited (BSE: 540596; NSE: ERIS) announced the launch of its generic Semaglutide under the brand 'SUNDAE' in India on March 21, 2026. The company aims to increase accessibility to advanced diabetes care with the introduction of this GLP-1 receptor agonist.Semaglutide, a GLP-1 receptor agonist, is a transformative therapy for Type 2 diabetes and weight management. Eris is introducing SUNDAE in multi-dose vial formats starting at Rs 1,290 per month for the 2 mg/1.5 ml and 4 mg/3 ml variants. A pen-device version is planned for April, priced at MRP of INR 4,000, INR 4,200 and INR 4,500 per month for the strengths 2mg/1.5ml, 4mg/3ml and 8mg/3ml...
IIFL Capital Services Limited Allots Equity Shares to Employees
IIFL Capital Services Limited Allots Equity Shares to Employees Mumbai, March 20, 2026 – IIFL Capital Services Limited (formerly IIFL Securities Limited) announced today that its Nomination and Remuneration Committee approved the allotment of 20,919 equity shares to employees through the exercise of stock options under the IIFL Securities Limited Employee Stock Option Scheme - 2018 (IIFL ESOS - 2018).The newly allotted shares rank pari passu with existing equity shares. As a result of this allotment, the company's equity base has increased from 311,413,794 to 311,434,713 equity shares, each with a face value of 2 Rupees.Source:
Intense Technologies Limited Appoints Additional Directors
Intense Technologies Limited Appoints Additional Directors Intense Technologies Limited announced the appointment of two additional directors to its Board on March 20, 2026. The decisions were made at a Board of Directors meeting held on that date.Rajesh Kumar Agarwal has been appointed as an Additional Director (Non-Executive & Non-Independent) effective March 20, 2026, pending shareholder approval. He is a Charted Accountant with over four decades of professional experience in management consulting, strategy, and investment analysis, particularly in manufacturing and financial leadership roles. Mr. Agarwal is not related to any existing directors.Prithvi Tapadiya has also been appointed as an Additional Director (Non-Executive &...
State Bank of India Receives Income Tax Demand of ₹63,375.25 Crore
State Bank of India Receives Income Tax Demand of ₹63,375.25 Crore State Bank of India (SBI) announced today, March 20, 2026, that it has received an order from the Income Tax department demanding ₹63,375.25 crore, including interest, following scrutiny assessment proceedings for the Assessment Year 2023-24.The demand, issued by the Assessment Unit, stems from disallowances made on various grounds outlined in the order dated March 19, 2026, under Section 143(3) read with section 144C(3) and 144B of the Income Tax Act. SBI has previously engaged in litigation regarding similar grounds in prior years.According to the bank, this matter exceeds the materiality threshold and the bank intends to contest the order through the appropriate...
Piramal Finance Ltd. to Seek Board Approval for Fund Raising via NCDs
Piramal Finance Ltd. to Seek Board Approval for Fund Raising via NCDs Piramal Finance Ltd. announced on March 20, 2026, that its Board of Directors will convene a meeting on Friday, March 27, 2026. The meeting's agenda includes consideration and approval for fund raising through the issuance of Non-Convertible Debentures on a private placement basis. The company's BSE Scrip Code is 544597 and NSE Symbol is PIRAMALFIN.Source:
SAB Events & Governance Now Media Ltd. Announces Trading Window Closure
SAB Events & Governance Now Media Ltd. Announces Trading Window Closure SAB Events & Governance Now Media Limited has announced the closure of its trading window for all insiders, designated persons, and connected persons. The closure, as per the company's code of conduct for insider trading aligned with the Securities and Exchange Board of India (SEBI) regulations, will be effective from April 1, 2026.The trading window will remain closed until 48 hours after the declaration of the company's audited financial results for the quarter and year ended March 31, 2026. The date of the board meeting to consider and approve these financial results will be communicated separately.Source:
B. P. Capital Ltd. Appoints New Director and Schedules Extraordinary General Meeting
B. P. Capital Ltd. Appoints New Director and Schedules Extraordinary General Meeting B. P. Capital Limited announced on March 20, 2026, that its Board of Directors approved the appointment of Mr. Faizal Bavaraparambil Abdul Khader (DIN: 07729191) as a Non-Executive Director. The appointment was based on the recommendation of the Nomination and Remuneration Committee, and Mr. Khader is not related to any existing directors.The Board also scheduled an Extraordinary General Meeting (EGM) for shareholders on April 20, 2026, at 10:00 A.M. at the company's registered office in Sohna, Haryana. E-voting will be conducted from April 17, 2026, to April 19, 2026. Central Depository Services Limited (CDSL) has been appointed as the depository to...
Yes Bank Allots Equity Shares Following Stock Option Exercise
Yes Bank Allots Equity Shares Following Stock Option Exercise Yes Bank Limited announced on March 20, 2026, that its Nomination & Remuneration Committee approved the allotment of 126,250 equity shares, each with a face value of Rs. 2. The allotment followed the exercise of 126,250 stock options under the YBL PESOP 2020 Plan and YBL RSU Plan 2024. The bank received Rs. 10,17,437.50 from the exercise of these options.The allotment has increased the bank's paid-up share capital from Rs. 62,759,261,614, comprising 31,379,630,807 equity shares, to Rs. 62,759,514,114, now consisting of 31,379,757,057 equity shares.Additional details regarding this allotment are available on the bank’s website, www.yes.bank.in.Source:
Paisalo Digital Limited Obtains Credit Ratings from Brickwork Ratings
Paisalo Digital Limited Obtains Credit Ratings from Brickwork Ratings Paisalo Digital Limited has received a BWR A1+ rating for its proposed Commercial Paper of ₹540 crore and reaffirmed the BWR AA/Stable rating for its proposed NCD issue of ₹1500 crore from Brickwork Ratings India Private Limited.The company’s rated facilities now include a Commercial Paper of ₹540 crore and a NCD issue of ₹1500 crore. Instruments with the BWR A1+ rating are considered to have a high degree of safety regarding the timely servicing of financial obligations.Paisalo Digital Limited’s total rated facilities now stand at ₹2040 crore, comprising a NCD issue of ₹1500 crore and a Commercial Paper of ₹540 crore.InstrumentAmount (₹ Crores) -...
Eris Lifesciences Ltd Announces Strategic Partnership with Natco Pharma Ltd for Semaglutide Launch in India
Eris Lifesciences Ltd Announces Strategic Partnership with Natco Pharma Ltd for Semaglutide Launch in India Ahmedabad, India - February 24, 2026 - Eris Lifesciences Limited (BSE: 540596; NSE: ERIS), a leading Indian branded formulations company, announced a strategic partnership with Natco Pharma Limited for the commercialization of Semaglutide in India. This collaboration reinforces Eris's commitment to expanding its leadership in the diabetes and metabolic care segment.Semaglutide, a GLP-1 receptor agonist, has gained global recognition as a transformative therapy for Type 2 diabetes and chronic weight management, demonstrating robust clinical outcomes in glycemic control and weight reduction. With India's rapidly growing diabetic...
Gem Aromatics Limited Discloses Acquisition of Shares
Gem Aromatics Limited Discloses Acquisition of Shares Gem Aromatics Limited announced on March 20, 2026, that it received a disclosure regarding a share acquisition from Mrs. Kaksha Vipul Parekh, a designated person and part of the promoter group.According to the disclosure, Mrs. Parekh acquired 60,000 shares, representing 0.11% of the company’s equity. This acquisition increased Mrs. Parekh’s total holding in Gem Aromatics Limited, along with persons acting in concert, to 49,03,219 shares, or 9.38% of the company’s total share/voting capital and 9.38% of the diluted share/voting capital.Prior to the acquisition, Mrs. Parekh and persons acting in concert held 48,43,219 shares, representing 9.27% of the company’s total share/voting...
Back
Top